{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:11:13Z","timestamp":1762909873125,"version":"3.45.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine and Research"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.resmer.2022.100894","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T02:30:43Z","timestamp":1645756243000},"page":"100894","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Chronic bronchial infection in stable COPD: An under-recognized situation that needs attention"],"prefix":"10.1016","volume":"81","author":[{"given":"Thais","family":"Beauperthuy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amina","family":"Bekki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7321-1891","authenticated-orcid":false,"given":"Miguel \u00c1ngel","family":"Mart\u00ednez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.resmer.2022.100894_bib0001","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJMra1900475","article-title":"Update on the pathogenesis of chronic obstructive pulmonary disease","volume":"26","author":"Agusti","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resmer.2022.100894_bib0002","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.arbres.2019.06.004","article-title":"Clinical control in COPD\u2013A new therapeutic objective?","volume":"56","author":"Soler-Catalu\u00f1a","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.resmer.2022.100894_bib0003","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.arbr.2019.04.017","article-title":"Establishing the prognosis of COPD exacerbations using risk scales from the point of view of the emergency department","volume":"56","author":"Garcia Sanz","year":"2020","journal-title":"Arch Bronconeumol"},{"issue":"11","key":"10.1016\/j.resmer.2022.100894_bib0004","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/thx.2005.040527","article-title":"Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease","volume":"60","author":"Soler-Catalu\u00f1a","year":"2005","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.resmer.2022.100894_bib0005","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.arbres.2019.10.005","article-title":"Dependence IN performing activities as a predictor of mortality following hospitalization for chronic obstructive pulmonary disease exacerbation","volume":"56","author":"Fern\u00e1ndez-Garc\u00eda","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.resmer.2022.100894_bib0006","unstructured":"Global Strategy For The Diagnosis, Management, and prevention of chronic obstructive pulmonary disease. 2021 Report. https:\/\/goldcopd.org\/wp-content\/uploads\/2020\/11\/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf [Accessed July 22th, 2021]"},{"issue":"5","key":"10.1016\/j.resmer.2022.100894_bib0007","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.arbr.2019.11.009","article-title":"Coping with low mortality and exacerbations rate differences between COPD triple therapy studies, and a proposal for upcoming studies","volume":"56","author":"Ruano","year":"2020","journal-title":"Arch Bronconeumol (Engl Ed)"},{"key":"10.1016\/j.resmer.2022.100894_bib0008","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.arbres.2019.11.011","article-title":"The clinical implications of triple therapy in fixed-dose combination in COPD\u2013From the trial to the patient","volume":"56","author":"L\u00f3pez-Campos","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.resmer.2022.100894_bib0009","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.2147\/COPD.S200846","article-title":"The effects of single inhaler triple therapy vs single inhaler dual therapy or separate triple therapy for the management of chronic obstructive pulmonary disease\u2013A systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Lai","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.resmer.2022.100894_bib0010","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.arbr.2020.08.006","article-title":"Consensus document on the diagnosis and treatment of chronic bronchial infection in chronic obstructive pulmonary disease","volume":"56","author":"de la Rosa","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.resmer.2022.100894_bib0011","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/resp.13032","article-title":"The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD","volume":"22","author":"Leung","year":"2017","journal-title":"Respirol"},{"key":"10.1016\/j.resmer.2022.100894_bib0012","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/cid\/ciaa069","article-title":"Bronchial infection and temporal evolution of bronchiectasis in patients with chronic obstructive pulmonary disease","volume":"72","author":"Martinez-Garcia","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.resmer.2022.100894_bib0013","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cmi.2019.06.011","article-title":"Pseudomonas aeruginosa and risk of death and exacerbations in patients with chronic obstructive pulmonary disease\u2013An observational cohort study of 22 053 patients","volume":"26","author":"Eklof","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.resmer.2022.100894_bib0014","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.rmed.2012.10.024","article-title":"Chronic bronchial infection in COPD. Is there an infective phenotype?","volume":"107","author":"Matkovic","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.resmer.2022.100894_bib0015","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/15412555.2021.1884214","article-title":"Risk factors and relation with mortality of a new acquisition and persistence of Pseudomonas aeruginosa in COPD patients","volume":"18","author":"Martinez-Garcia","year":"2021","journal-title":"COPD"},{"issue":"2","key":"10.1016\/j.resmer.2022.100894_bib0016","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.arbr.2017.07.013","article-title":"Spanish guidelines on the evaluation and diagnosis of bronchiectasis in adults","volume":"54","author":"Martinez-Garcia","year":"2018","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.resmer.2022.100894_bib0017","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00629-2017","article-title":"European respiratory society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur Resp J"},{"issue":"5","key":"10.1016\/j.resmer.2022.100894_bib0018","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.arbres.2019.08.023","article-title":"Clinical characteristics and risk of exacerbations associated with different diagnostic criteria of asthma-COPD overlap","volume":"56","author":"Soler-Catalu\u00f1a","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.resmer.2022.100894_bib0019","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1164\/rccm.201908-1550OC","article-title":"Inhaled steroids, circulating eosinophils, chronic airway infection and pneumonia risk in chronic obstructive pulmonary disease\u2013A network analysis","volume":"201","author":"Martinez-Garcia","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resmer.2022.100894_bib0020","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.2147\/COPD.S179425","article-title":"Blood eosinophils\u2013A biomarker of COPD exacerbation reduction with inhaled corticosteroids","volume":"13","author":"Siddiqui","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.resmer.2022.100894_bib0021","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.arbres.2021.08.001","article-title":"Bronchiectasis and eosinophils","volume":"57","author":"Martinez-Garcia","year":"2021","journal-title":"Arch Bronconeumol"},{"issue":"2","key":"10.1016\/j.resmer.2022.100894_bib0022","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00453-2020","article-title":"Blood eosinophils predict inhaled fluticasone response in bronchiectasis","volume":"56","author":"Aliberti","year":"2020","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.resmer.2022.100894_bib0023","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.arbr.2020.06.003","article-title":"Repeteability of circulating eosinophil measures and inhaled corticosteroids effect in bronchiectasis. A post hoc analysis of a randomized clinical trial","volume":"56","author":"Martinez-Garcia","year":"2020","journal-title":"Arch Bronconeumol (Engl Ed)"},{"key":"10.1016\/j.resmer.2022.100894_bib0024","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.2147\/COPD.S181246","article-title":"Long-term macrolide treatment for the prevention of acute exacerbations in COPD\u2013A systematic review and meta-analysis","volume":"13","author":"Cui","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.resmer.2022.100894_bib0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.arbres.2020.04.016","article-title":"Chronic obstructive pulmonary disease and SARS-CoV-2 infection. What do we know so far?","volume":"56","author":"Figueira Gon\u00e7alves","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.resmer.2022.100894_bib0026","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/thoraxjnl-2020-216083","article-title":"COVID-19 public health measures\u2013A reduction in hospital admissions for COPD exacerbations","volume":"76","author":"Tan","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.resmer.2022.100894_bib0027","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.arbres.2021.01.001","article-title":"COPD and COVID-19","volume":"57","author":"Halpin","year":"2021","journal-title":"Arch Bronconeumol"},{"issue":"9","key":"10.1016\/j.resmer.2022.100894_bib0028","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.arbres.2020.05.007","article-title":"Asthma and COPD in hospitalized COVID-19 patients","volume":"56","author":"Garc\u00eda-Pach\u00f3n","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.resmer.2022.100894_bib0029","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S2213-2600(21)00095-3","article-title":"Association between pre-existing respiratory disease and its treatment, and severe COVID-19\u2013A population cohort study","volume":"9","author":"Aveyard","year":"2021","journal-title":"Lancet Resp Med"},{"key":"10.1016\/j.resmer.2022.100894_bib0030","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.arbr.2021.04.017","article-title":"Bronchiectasis as a long-term consequence of SARS-COVID-19 Pneumonia\u2013Future studies are needed","volume":"57","author":"Martinez-Garcia","year":"2021","journal-title":"Arch Bronconeumol (Engl Ed)"},{"key":"10.1016\/j.resmer.2022.100894_bib0031","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.arbr.2019.04.014","article-title":"The microbiome in chronic obstructive lung disease and cystic fibrosis","volume":"56","year":"2020","journal-title":"Arch Bronconeumol"}],"container-title":["Respiratory Medicine and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041222000113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041222000113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:07:31Z","timestamp":1762909651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590041222000113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":31,"alternative-id":["S2590041222000113"],"URL":"https:\/\/doi.org\/10.1016\/j.resmer.2022.100894","relation":{},"ISSN":["2590-0412"],"issn-type":[{"type":"print","value":"2590-0412"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic bronchial infection in stable COPD: An under-recognized situation that needs attention","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine and Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resmer.2022.100894","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 SPLF and Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100894"}}